Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
15.91
-0.05 (-0.31%)
At close: Nov 20, 2024, 4:00 PM
14.20
-1.71 (-10.75%)
Pre-market: Nov 21, 2024, 4:17 AM EST
Kura Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 67.27 | 50.57 | 47.05 | 46.54 | 31.5 | 19.65 | |
Research & Development | 150.23 | 115.24 | 92.81 | 84.72 | 60.4 | 47.83 | |
Operating Expenses | 217.5 | 165.8 | 139.87 | 131.26 | 91.9 | 67.48 | |
Operating Income | -217.5 | -165.8 | -139.87 | -131.26 | -91.9 | -67.48 | |
Interest Expense | -1.61 | -1.55 | -0.23 | -0.41 | -0.58 | -0.58 | |
Interest & Investment Income | 12.14 | 5.3 | 5.86 | 5.6 | 3.26 | 3.82 | |
EBT Excluding Unusual Items | -206.97 | -162.05 | -134.23 | -126.08 | -89.22 | -64.24 | |
Gain (Loss) on Sale of Investments | 9.42 | 9.42 | -1.61 | -4.39 | -0.41 | 1.1 | |
Pretax Income | -197.55 | -152.63 | -135.84 | -130.47 | -89.63 | -63.14 | |
Net Income | -197.55 | -152.63 | -135.84 | -130.47 | -89.63 | -63.14 | |
Net Income to Common | -197.55 | -152.63 | -135.84 | -130.47 | -89.63 | -63.14 | |
Shares Outstanding (Basic) | 84 | 73 | 67 | 66 | 53 | 42 | |
Shares Outstanding (Diluted) | 84 | 73 | 67 | 66 | 53 | 42 | |
Shares Change (YoY) | 18.20% | 9.31% | 0.96% | 25.01% | 26.54% | 19.20% | |
EPS (Basic) | -2.36 | -2.08 | -2.03 | -1.97 | -1.69 | -1.51 | |
EPS (Diluted) | -2.36 | -2.08 | -2.03 | -1.97 | -1.69 | -1.51 | |
Free Cash Flow | -169.24 | -124.99 | -110.69 | -105.7 | -72 | -54.76 | |
Free Cash Flow Per Share | -2.02 | -1.71 | -1.65 | -1.59 | -1.36 | -1.31 | |
EBITDA | -216.64 | -164.96 | -139.11 | -130.7 | -91.71 | -67.47 | |
D&A For EBITDA | 0.86 | 0.85 | 0.76 | 0.56 | 0.19 | 0.01 | |
EBIT | -217.5 | -165.8 | -139.87 | -131.26 | -91.9 | -67.48 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.